Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Indian (NIFTY) Clinical Research and Equipment Industry Analysis

UpdatedJun 14, 2026
DataAggregated Company Financials
Companies22
  • 7D1.1%
  • 3M15.0%
  • 1Y-2.3%
  • YTDn/a

The Clinical Research and Equipment industry is up 1.1% in the last week, with Anthem Biosciences up 3.6%. In the same time, OneSource Specialty Pharma was down 9.9%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 24% per annum.

Industry Valuation and Performance

Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 14 Jun 2026₹3.3t₹361.7b₹46.4b38.8x70.8x9.1x
Tue, 12 May 2026₹3.3t₹354.7b₹45.7b34.7x72x9.3x
Thu, 09 Apr 2026₹2.8t₹350.2b₹46.2b29.5x61.6x8.1x
Sat, 07 Mar 2026₹3.0t₹350.2b₹46.2b28.9x63.9x8.4x
Mon, 02 Feb 2026₹2.8t₹344.9b₹46.4b26.5x60.4x8.1x
Wed, 31 Dec 2025₹3.1t₹342.6b₹48.4b33.1x64x9x
Fri, 28 Nov 2025₹3.1t₹342.6b₹48.4b33.3x64x9x
Sun, 26 Oct 2025₹3.2t₹331.4b₹45.5b42.7x71.2x9.8x
Tue, 23 Sep 2025₹3.2t₹331.4b₹45.5b47.5x70.1x9.6x
Thu, 21 Aug 2025₹3.2t₹331.4b₹45.5b43.9x69.9x9.6x
Sat, 19 Jul 2025₹3.2t₹319.5b₹41.7b52.7x76.9x10x
Mon, 16 Jun 2025₹2.9t₹299.7b₹37.2b47.1x77.5x9.6x
Wed, 14 May 2025₹2.6t₹292.8b₹32.3b47.4x81.3x9x
Fri, 11 Apr 2025₹2.4t₹287.4b₹30.8b41.8x77.6x8.3x
Sun, 09 Mar 2025₹2.4t₹287.4b₹30.8b47.8x79.5x8.5x
Tue, 04 Feb 2025₹2.4t₹270.7b₹30.5b48x80.1x9x
Thu, 02 Jan 2025₹2.6t₹269.1b₹30.1b53.3x86.2x9.6x
Sat, 30 Nov 2024₹2.5t₹254.2b₹28.8b49.4x86.3x9.8x
Mon, 28 Oct 2024₹2.3t₹247.4b₹26.2b50x89.7x9.5x
Wed, 25 Sep 2024₹2.3t₹247.6b₹26.3b50x86.2x9.2x
Fri, 23 Aug 2024₹2.1t₹247.1b₹23.8b38.7x88.6x8.5x
Sun, 21 Jul 2024₹1.8t₹201.9b₹23.9b37.7x74.6x8.8x
Tue, 18 Jun 2024₹1.8t₹194.5b₹21.5b34.3x82.1x9.1x
Thu, 16 May 2024₹1.6t₹194.1b₹21.6b33.1x72.5x8.1x
Sat, 13 Apr 2024₹1.4t₹168.5b₹18.6b29.5x77.5x8.6x
Mon, 11 Mar 2024₹1.4t₹168.5b₹18.6b31.1x74x8.2x
Wed, 07 Feb 2024₹1.4t₹166.6b₹19.0b33.2x75.7x8.6x
Fri, 05 Jan 2024₹1.5t₹155.9b₹18.1b25.2x81.3x9.4x
Sun, 03 Dec 2023₹1.4t₹155.9b₹18.1b22.3x77.3x9x
Tue, 31 Oct 2023₹1.3t₹156.1b₹19.8b20.6x63.7x8.1x
Thu, 28 Sep 2023₹1.4t₹154.7b₹19.7b25.8x71.2x9.1x
Sat, 26 Aug 2023₹1.4t₹154.7b₹19.7b27.6x69.2x8.8x
Mon, 24 Jul 2023₹1.4t₹156.5b₹23.0b30x59.9x8.8x
Wed, 21 Jun 2023₹1.3t₹157.2b₹23.0b28.7x57.8x8.5x
Price to Earnings Ratio

57.8x


Total Market Cap: ₹1.3tTotal Earnings: ₹23.0bTotal Revenue: ₹157.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Indian Clinical Research and Equipment Industry Price to Earnings3Y Average 74x202420252026
Current Industry PE
  • Investors are pessimistic on the Indian Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 70.8x which is lower than its 3-year average PE of 74.0x.
  • The industry is trading close to its 3-year average PS ratio of 9.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 32% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Indian Clinical Research and Equipment compare with similar industries?

IN Market0.052%
Healthcare1.23%
Life Sciences1.08%
Clinical Research and Equipment1.08%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ANTHEM Anthem Biosciences₹788.703.6%
+₹15.3b		n/aPE74.8x
AKUMS Akums Drugs and Pharmaceuticals₹622.9012.5%
+₹10.6b		8.8%PE37.4x
SYNGENE Syngene International₹458.555.6%
+₹9.7b		-29.8%PE57.6x
530239 Suven Life Sciences₹268.6013.3%
+₹8.3b		14.0%PS995.6x
SAILIFE Sai Life Sciences₹1.22k2.7%
+₹6.7b		58.2%PE74.1x

Latest News

524394
₹554.10
Vimta Labs
7D
1.9%
1Y
7.8%
INNOVACAP
₹942.45
Innova Captab
7D
8.6%
1Y
3.9%
DIVISLAB
₹6,638.00
Divi's Laboratories
7D
0.2%
1Y
-0.4%
Narrative Update • Jun 09

DIVISLAB: Upcoming Board Meeting And Dividend Decision Will Support Bullish Outlook

Analysts have raised their fair value estimate for Divi's Laboratories from ₹8,620.23 to ₹8,812.63, reflecting updated assumptions for the discount rate, revenue growth, profit margins and future P/E expectations. What's in the News A board meeting is scheduled for May 23, 2026, at 10:15 IST to review and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
SYNGENE
₹458.55
Syngene International
7D
5.6%
1Y
-29.8%
Narrative Update • Jun 04

SYNGENE: New Drug Manufacturing Partnership Will Support Future Earnings

Analysts have maintained their fair value estimate for Syngene International at ₹578.13 per share, with only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, resulting in a largely unchanged price target narrative. What's in the News Biodexa Pharmaceuticals PLC partnered with Syngene International for the manufacture of MTX240 active pharmaceutical ingredient and dosage form, using molecular glue technology for rare oncology indications, source: Client Announcements.
INDGN
₹510.35
Indegene
7D
-2.4%
1Y
-14.8%
Narrative Update • Jun 02

INDGN: Tax Resolution Path And Dividend Prospects Will Drive Future Upside

Analysts have left their fair value estimate for Indegene broadly unchanged at around ₹592. A slightly higher discount rate and a marginally higher future P/E assumption are the main reasons cited for maintaining the same price target.
511509
₹23.77
Vivo Bio Tech
7D
-2.8%
1Y
-37.5%
526853
₹60.00
Bilcare
7D
-6.1%
1Y
-24.2%
INFLUX
₹238.15
Influx Healthtech
7D
-0.4%
1Y
n/a
Analysis Article • May 28

Investors Shouldn't Be Too Comfortable With Influx Healthtech's (NSE:INFLUX) Earnings

Investors were disappointed with Influx Healthtech Limited's ( NSE:INFLUX ) earnings, despite the strong profit...
TARSONS
₹205.35
Tarsons Products
7D
-2.6%
1Y
-47.4%
DCAL
₹184.64
Dishman Carbogen Amcis
7D
-2.8%
1Y
-34.0%
AKUMS
₹622.90
Akums Drugs and Pharmaceuticals
7D
12.5%
1Y
8.8%
Analysis Article • May 22

There May Be Reason For Hope In Akums Drugs and Pharmaceuticals' (NSE:AKUMS) Disappointing Earnings

The market for Akums Drugs and Pharmaceuticals Limited's ( NSE:AKUMS ) shares didn't move much after it posted weak...
SAILIFE
₹1,218.10
Sai Life Sciences
7D
2.7%
1Y
58.2%
Analysis Article • May 22

Sai Life Sciences (NSE:SAILIFE) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Despite posting some strong earnings, the market for Sai Life Sciences Limited's ( NSE:SAILIFE ) stock hasn't moved...
ANTHEM
₹788.70
Anthem Biosciences
7D
3.6%
1Y
n/a
530239
₹268.60
Suven Life Sciences
7D
13.3%
1Y
14.0%
ONESOURCE
₹1,612.50
OneSource Specialty Pharma
7D
-9.9%
1Y
-20.4%
FABTECH
₹147.35
Fabtech Technologies
7D
-1.2%
1Y
n/a